Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK melanoma drug combination wins accelerated U.S. approval
GSK melanoma drug combination wins accelerated U.S. approval
GSK melanoma drug combination wins accelerated U.S. approval
Submitted by
admin
on January 9, 2014 - 8:37am
Source:
Yahoo/Reuters
News Tags:
GSK
FDA
Tafinlar
Mekinist
melanoma
Headline:
GSK melanoma drug combination wins accelerated U.S. approval
Do Not Allow Advertisers to Use My Personal information
